Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when USPH files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsU.S. Physical Therapy posts Q3 revenue up 13% to $223M, adjusted EPS $0.80, and declares $0.46 dividend
Filed November 6, 2026 · Period ending November 4, 2026 · ~1 min read
Key Changes
-
high
Q3 2026 total net revenue rose 13% to $223 million, driven by 13% growth in physical therapy and 14% in industrial injury prevention.
Exhibit 99 view on EDGAR → -
high
GAAP EPS swung to a loss of $1.04 from a profit of $0.48 a year ago, due to a $36.2 million revaluation of redeemable non-controlling interest.
Exhibit 99 view on EDGAR → -
high
Adjusted EPS increased to $0.80 from $0.66, and adjusted EBITDA rose to $28 million from $24 million.
Exhibit 99 view on EDGAR → -
high
Management reaffirmed full-year 2026 adjusted EBITDA guidance of $102 million to $106 million.
Exhibit 99 view on EDGAR → -
medium
Board declared a quarterly dividend of $0.46 per share, payable December 11, 2026 to shareholders of record November 16, 2026.
Item 8.01 verify on EDGAR →
Summary
U.S. Physical Therapy reported third-quarter 2026 results showing solid revenue growth and improved adjusted profitability, while a non-cash accounting item pushed GAAP earnings to a loss. Total net revenue increased 13% to $223 million, with both the physical therapy and industrial injury prevention segments contributing double-digit growth.
Adjusted EPS rose to $0.80 from $0.66, and adjusted EBITDA climbed to $28 million from $24 million. Management reaffirmed its full-year adjusted EBITDA guidance of $102 million to $106 million. The GAAP loss of $1.04 per share, compared with a profit of $0.48 a year earlier, stemmed from a $36.2 million revaluation of redeemable non-controlling interest.
This item is excluded from adjusted results and does not affect cash flow or the company's operating performance. The board also declared a quarterly dividend of $0.46 per share, up from $0.45, payable on December 11, 2026 to shareholders of record on November 16, 2026. For retail holders, the key takeaways are the continued revenue momentum, higher adjusted earnings, and a modest dividend increase. The GAAP loss is an accounting artifact rather than an operational setback, and the reaffirmed guidance provides a clear profitability target for the remainder of the year.
Section-by-Section Diff
Event · Item 2.02 — Results of Operations and Financial Condition
U.S. Physical Therapy reported Q3 and nine-month 2026 results on November 4, 2026 via press release.
Added in current filing · verify on EDGAR →
On November 4, 2026, U.S. Physical Therapy, Inc. (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, reported results for the three and nine months ended September 30, 2026.
The company announced its financial results for the third quarter and first nine months of fiscal 2026. The press release containing the detailed figures is attached as Exhibit 99.1. No specific financial metrics are quoted in the 8-K body itself.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Nov 9, 2026 · How we verify